Adagene Shares 2011-2026 | ADAG

Annual Shares Adagene

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
56.3 M	54.7 M	54.1 M	50 M	16 M	15.2 M	15.2 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
56.3 M	15.2 M	37.4 M

Quarterly Shares Adagene

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	54.6 M	-	-	-	16.6 M	-	-	-	15.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
54.6 M	15.2 M	28.8 M

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	1.24 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	12.1 M	-	4.01 %	$ 150 M	Canada
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	16.8 M	-	1052.0 %	$ 415 M	USA
Albireo Pharma ALBO	19.2 M	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	187 M	-	-	$ 866 M	China
ANI Pharmaceuticals ANIP	19.3 M	$ 81.6	-0.49 %	$ 1.58 B	USA
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Amgen AMGN	537 M	$ 342.65	-0.08 %	$ 184 B	USA
Aeglea BioTherapeutics AGLE	60.3 M	-	-	$ 1.01 B	USA
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Aytu BioScience AYTU	6.28 M	$ 2.63	1.74 %	$ 16.5 M	USA
Alterity Therapeutics Limited ATHE	2.41 B	$ 3.17	-2.76 %	$ 7.63 B	Australia
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
PainReform Ltd. PRFX	454 K	$ 0.68	-4.45 %	$ 308 K	Israel
Allena Pharmaceuticals ALNA	68 M	-	3.16 %	$ 1.9 M	USA
AVROBIO AVRO	44.3 M	-	1083.1 %	$ 745 M	USA
Aptose Biosciences APTO	699 K	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	36.4 M	-	-13.39 %	$ 1.45 M	USA
Biogen BIIB	146 M	$ 178.24	1.2 %	$ 26 B	USA
Brickell Biotech BBI	5.39 M	-	-5.38 %	$ 6.06 M	USA
Applied Molecular Transport AMTI	38.8 M	-	-	$ 10.1 M	USA
Beam Therapeutics BEAM	82.3 M	$ 27.94	-4.61 %	$ 2.3 B	USA
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Ascendis Pharma A/S ASND	54.8 M	$ 225.36	0.63 %	$ 5 B	Danmark
Athira Pharma ATHA	38.5 M	-	-	$ 269 M	USA
Atreca BCEL	38.6 M	-	-11.76 %	$ 5.79 M	USA
BioNTech SE BNTX	244 M	$ 114.18	-2.22 %	$ 27.2 B	Germany
Burford Capital Limited BUR	219 M	$ 9.67	0.16 %	$ 1.52 B	Britain
Arrowhead Pharmaceuticals ARWR	134 M	$ 70.74	2.34 %	$ 9.46 B	USA
CASI Pharmaceuticals CASI	136 M	$ 0.99	-0.01 %	$ 135 M	USA
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.08 K	-	-10.17 %	$ 12.2 K	USA
Catalyst Biosciences CBIO	65.8 M	$ 9.63	-5.08 %	$ 634 M	USA
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA
Bellicum Pharmaceuticals BLCM	30.8 M	-	-9.72 %	$ 5.89 M	USA
Adaptimmune Therapeutics plc ADAP	1.21 B	-	-15.15 %	$ 60.3 M	Britain
Berkeley Lights BLI	68.9 M	-	-7.31 %	$ 87 M	USA
Can-Fite BioPharma Ltd. CANF	2.18 B	$ 4.05	-1.22 %	$ 8.81 B	Israel
Amneal Pharmaceuticals AMRX	309 M	$ 13.65	-3.3 %	$ 4.22 B	USA
AIkido Pharma AIKI	6.18 M	-	1.93 %	$ 17.4 M	USA
Bellerophon Therapeutics BLPH	9.55 M	-	-74.18 %	$ 955 K	USA
Cerus Corporation CERS	185 M	$ 2.32	-0.22 %	$ 428 M	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	15.8 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	33.4 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.01 M	-	4.14 %	$ 49.1 M	USA